The protein alpha-synuclein is central to the pathophysiology of Parkinson's disease (PD) but its role in the development of neurodegeneration remains unclear. alpha-Synuclein-knockout mice develop without gross abnormality and are resistant to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a mitochondrial inhibitor widely used to model parkinsonism. Here we show that differentiated human dopaminergic neuron-like cells also have increased resistance to 1-methyl-4-phenylpyridine (MPP+), ...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
The effect of alpha-synuclein knockdown on MPP+ toxicity in models of human neurons.
Views and Downloads
If you are the owner of this record, you can report an update to it here: Report update to this record